close menu

Lorenz Blog

1 - 8 of 128
Release Highlights:

What's new in docuBridgeAmong the latest enhancements we make a big step towards eCTD 4.0 adoption and introduce an exciting development. With seamless eCTD 4.0 forward compatibility, you can now transition smoothly from eCTD v3.2 to v4.0, ensuring efficient, future-ready submissions. The Submission Repository has also been upgraded with structured pools, a new "Packages" location type, and improved workflows, offering more flexibility and control over file management. Plus, the new Audit Trail Timeline provides a clear, filterable view of all document changes, enhancing transparency and oversight. Discover more about these features here: What's new in docuBridge 24.2?

This entry was posted in LORENZ Solutions and Services.

Sneak peek at our upcoming 24.2 releases

Posted on October 24, 2024

Sneak peek at the docuBridge 24.2 release:

This entry was posted in LORENZ Solutions and Services.

Last month, we had the pleasure of hosting LORENZ Converge 2024 in Berlin, where regulatory affairs professionals from around the world came together for two days of knowledge sharing, networking, and collaboration. As the successor to both LORENZ userBridge and LORENZlink, Converge represents the best of both events, creating a global platform that bridges perspectives from all over the world.


A Global Gathering of Experts

The event was a huge success, and we were thrilled to see such a diverse group of attendees representing regulatory authorities, life sciences companies, and industry thought leaders. Participants from four continents—Asia, Africa, North America, and Europe—joined the conference, further enhancing the global exchange of knowledge. One of the key objectives of LORENZ Converge is fostering networking, and we saw countless interactions between participants—old acquaintances reconnecting and new partnerships being formed. This exchange of ideas is one of the main reasons we believe events like this are so crucial to the regulatory community.

This entry was posted in LORENZ Events.

Established in December 2021, the drugTrack userGroup was directly inspired by the success of its sister, the docuBridge userGroup. It is run by users and supported by LORENZ to share insights on working with LORENZ drugTrack.



This entry was posted in LORENZ News.

In September 2021 Theo van der Zee and Philip Hall, two LORENZ customers started the userGroup: A forum to discuss issues with docuBridge as well as best practices in using it. There is no doubt that the userGroup was a welcomed initiative as after just over two years, we are happy to have over 350 members representing around 115 companies.



This entry was posted in LORENZ News.

Release Highlights:

What's new in docuBridge? Unlock enhanced productivity with docuBridge's latest release! Seamlessly collaborate with our User Notification Center, receiving instant updates on document annotations and interactions. Stay engaged with notifications triggered by note modifications, fostering teamwork and streamlining communication. Effortlessly organize your workspace with multiple content panes in webAccess, enhancing workflow efficiency. Simplify PDF comparison in the Submission Workbench, saving time and ensuring accuracy in document analysis. Click here to read more about these highlights: What's new in docuBridge 24.1?

This entry was posted in LORENZ Solutions and Services.

Sneak peek at our upcoming 24.1 releases

Posted on April 24, 2024

Sneak peek at the docuBridge 24.1 release:

This entry was posted in LORENZ Solutions and Services.

First and foremost, we want to thank all speakers and attendees who joined this year’s LORENZ Connect 2024! It was a pleasure to witness the gathering of about 500 minds from almost 40 countries around the globe, coming online together to delve into the latest developments and trends shaping the landscape of Regulatory Affairs within the life sciences industry.

 

This entry was posted in LORENZ Events.

1 - 8 of 128
© Copyright LORENZ Life Sciences Group. All rights reserved.